Bioventus
Bioventus develops innovations in pain treatment, restorative therapies, and surgical solutions to help patients resume active lives. Learn more
Launch date
Employees
Market cap
AUD1.1b
Enterprise valuation
AUD1.7b (Public information from Sep 2024)
Share price
$11.59 BVS
Durham North Carolina (HQ)
Authorizing premium user...